Search Results - "NIGEN, SIMON"

Refine Results
  1. 1

    Inhibition of IL-13: A New Pathway for Atopic Dermatitis by Ratnarajah, Kayadri, Le, Michelle, Muntyanu, Anastasiya, Mathieu, Steve, Nigen, Simon, Litvinov, Ivan V., Jack, Carolyn S., Netchiporouk, Elena

    Published in Journal of Cutaneous Medicine and Surgery (01-05-2021)
    “…Dupilumab, a monoclonal antibody against the common receptor of interleukin (IL)-4 and IL-13, was the first biologic therapy approved in Canada for treatment…”
    Get full text
    Book Review Journal Article
  2. 2

    Palmoplantar pustular psoriasis (PPPP) is characterized by activation of the IL-17A pathway by Bissonnette, Robert, Fuentes-Duculan, Judilyn, Mashiko, Shunya, Li, Xuan, Bonifacio, Kathleen M, Cueto, Inna, Suárez-Fariñas, Mayte, Maari, Catherine, Bolduc, Chantal, Nigen, Simon, Sarfati, Marika, Krueger, James G

    Published in Journal of dermatological science (01-01-2017)
    “…Highlights • IL-1β/IL-6/LL-37/IL-19/IL-17A/CXCL1/CXCL2 increased in PPPP as compared to NPPPP. • No significant difference of IL-23 in PPPP as compared to…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    Secukinumab versus guselkumab in the complete resolution of ustekinumab-resistant psoriatic plaques: The ARROW study by Krueger, James, Langley, Richard G, Nigen, Simon, Kasparek, Torben, Comite, Gabriele Di, Ortmann, Christine-Elke, Garcet, Sandra, Kolbinger, Frank, Reich, Kristian

    Published in Experimental dermatology (01-10-2023)
    “…Interleukin (IL)-23-independent IL-17A production has been suggested to be involved in persistent manifestations of psoriatic disease, including…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Effect of adalimumab on sleep parameters in patients with psoriasis and obstructive sleep apnea: a randomized controlled trial by Maari, Catherine, Bolduc, Chantal, Nigen, Simon, Marchessault, Philippe, Bissonnette, Robert

    Published in The Journal of dermatological treatment (01-02-2014)
    “…Introduction: Obstructive sleep apnea (OSA) is frequently seen in patients with psoriasis vulgaris. The effect of adalimumab, a TNF-α antagonist, on OSA is…”
    Get full text
    Journal Article
  11. 11

    A Patient Charter for Chronic Urticaria by Maurer, Marcus, Albuquerque, Mónica, Boursiquot, Jean-Nicolas, Dery, Elaine, Giménez-Arnau, Ana, Godse, Kiran, Guitiérrez, Guillermo, Kanani, Amin, Lacuesta, Gina, McCarthy, Jessica, Nigen, Simon, Winders, Tonya

    Published in Advances in therapy (2024)
    “…Chronic urticaria (CU) is the recurring development of wheals (aka “hives” or “welts”), angioedema, or both for more than 6 weeks. Wheals and angioedema occur…”
    Get full text
    Journal Article
  12. 12

    Open-label exploratory study of acitretin for the treatment of severe chronic hand dermatitis by Tan, Jerry, Maari, Catherine, Nigen, Simon, Bolduc, Chantal, Bissonnette, Robert

    Published in The Journal of dermatological treatment (04-07-2015)
    “…Introduction: Acitretin is a retinoid approved for the treatment of psoriasis that has good efficacy for palmoplantar psoriasis. The safety and efficacy of…”
    Get full text
    Journal Article
  13. 13

    Influence of the quantity of sunscreen applied on the ability to protect against ultraviolet-induced polymorphous light eruption by Bissonnette, Robert, Nigen, Simon, Bolduc, Chantal

    “…Summary Background/Purpose Despite the fact that most people apply less sunscreen than the 2 mg/cm2 required to measure sun protection factor (SPF), there is a…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Efficacy and Tolerability of Topical Tacrolimus Ointment for the Treatment of Male Genital Psoriasis by Bissonnette, Robert, Nigen, Simon, Bolduc, Chantal

    Published in Journal of cutaneous medicine and surgery (01-09-2008)
    “…Background: Genital psoriasis is difficult to treat and has a significant psychological impact on affected patients. Objective: To study the safety and…”
    Get full text
    Journal Article
  16. 16

    Photodynamic therapy with methylaminolevulinate 80 mg/g without occlusion improves acne vulgaris by Bissonnette, Robert, Maari, Catherine, Nigen, Simon, Provost, Nathalie, Bolduc, Chantal

    Published in Journal of drugs in dermatology (01-11-2010)
    “…Photodynamic therapy (PDT) with methylaminolevulinate (MAL) under occlusion is effective for the treatment of acne vulgaris but is associated with significant…”
    Get more information
    Journal Article
  17. 17
  18. 18

    A double-blind study of tolerance and efficacy of a new urea-containing moisturizer in patients with atopic dermatitis by Bissonnette, Robert, Maari, Catherine, Provost, Nathalie, Bolduc, Chantal, Nigen, Simon, Rougier, André, Seite, Sophie

    Published in Journal of cosmetic dermatology (01-03-2010)
    “…Summary Background  Atopic dermatitis patients almost all use moisturizers to prevent and treat their skin disease. However, the safety and efficacy of…”
    Get full text
    Journal Article
  19. 19

    Drug eruptions: approaching the diagnosis of drug-induced skin diseases by Nigen, Simon, Knowles, Sandra R, Shear, Neil H

    Published in Journal of drugs in dermatology (01-06-2003)
    “…Adverse drug reactions are a major problem in drug therapy, and cutaneous drug reactions account for a large proportion of all adverse drug reactions…”
    Get more information
    Journal Article
  20. 20

    Protection Afforded by Sunscreens Containing Inorganic Sunscreening Agents Against Blue Light Sensitivity Induced by Aminolevulinic Acid by BISSONNETTE, ROBERT, NIGEN, SIMON, BOLDUC, CHANTAL, MÉRY, SOPHIE, NOCERA, THÉRÈSE

    Published in Dermatologic surgery (01-11-2008)
    “…BACKGROUND Application of aminolevulinic acid (ALA) for photodynamic therapy induces significant sensitivity to visible light. OBJECTIVE To determine whether…”
    Get full text
    Journal Article